In cancer studies many patients will never experience the event of concern and are hence considered as cured. Therefore, the main interest of the cancer trials is in determining the fraction of cured patients so as to obtain the trends in the survival of cancer patients. Survival models incorporate the cure fraction in the analysis; namely cure rate models, are being widely used in cancer studies, where one of the most common cure models that can be employed in cancer clinical trials is the bounded cumulative hazard (BCH) model. In this thesis, we considered two methods via the expectation maximization (EM) algorithm for cure rate estimation based on the BCH model using the two censoring types common to cancer clinical trials; namely, righ...
Copyright © 2013 Shunzo Maetani, John W. Gamel. This is an open access article distributed under the...
Cure rate estimation is one of the most important issues in clinical trials and cure rate models are...
Cure rate models are survival models consisting of a cured fraction and an uncured fraction. These m...
This study deals with the analysis of the cure rate estimation based on the Bounded Cumulative Hazar...
A significant proportion of patients in cancer clinical trials can be cured. That is, the symptoms o...
In cancer clinical trials, a significant fraction of patients can be cured, that is, the symptoms of...
Medical investigations nowadays allow the incorporation of cure individuals in the analysis, especia...
In this article, we consider the Bounded Cumulative Hazard (BCH) model that is more appropriate than...
With the ongoing advance in the medical sciences, we may quite often encounter data sets where some ...
In population based cancer clinical trials, a proportion of patients will never experience the inter...
Estimating cure-rate is a popular research topic in the study of immunity of individuals against ter...
In population-based cancer studies, cure is said to occur when the mortality (hazard)rate in the dis...
In most recent clinical studies, the focus is on estimation of the proportion of patients who are cu...
This article considers the utility of the bounded cumulative hazard model in cure rate estimation, w...
In survival studies, it is often of interest to study cure rates. Sometimes the event of interest (s...
Copyright © 2013 Shunzo Maetani, John W. Gamel. This is an open access article distributed under the...
Cure rate estimation is one of the most important issues in clinical trials and cure rate models are...
Cure rate models are survival models consisting of a cured fraction and an uncured fraction. These m...
This study deals with the analysis of the cure rate estimation based on the Bounded Cumulative Hazar...
A significant proportion of patients in cancer clinical trials can be cured. That is, the symptoms o...
In cancer clinical trials, a significant fraction of patients can be cured, that is, the symptoms of...
Medical investigations nowadays allow the incorporation of cure individuals in the analysis, especia...
In this article, we consider the Bounded Cumulative Hazard (BCH) model that is more appropriate than...
With the ongoing advance in the medical sciences, we may quite often encounter data sets where some ...
In population based cancer clinical trials, a proportion of patients will never experience the inter...
Estimating cure-rate is a popular research topic in the study of immunity of individuals against ter...
In population-based cancer studies, cure is said to occur when the mortality (hazard)rate in the dis...
In most recent clinical studies, the focus is on estimation of the proportion of patients who are cu...
This article considers the utility of the bounded cumulative hazard model in cure rate estimation, w...
In survival studies, it is often of interest to study cure rates. Sometimes the event of interest (s...
Copyright © 2013 Shunzo Maetani, John W. Gamel. This is an open access article distributed under the...
Cure rate estimation is one of the most important issues in clinical trials and cure rate models are...
Cure rate models are survival models consisting of a cured fraction and an uncured fraction. These m...